The objective of Core A is to maintain a large collection of venoms and tissues from different Conus speciesand a library of purified venom peptides, synthetic peptides and their analogs. Biological materials will becollected mainly from various locations in the Phillipines. While the venom will be used as a direct source ofpurified peptides, tissues will be used as source of mRNA and genomic DNA for the molecular biologicalidentification of toxins. Peptides will be identified both by biochemical purification and by molecularbiological identification of peptide-encoding nucleic acid sequences. From a knowledge of the evolutionaryrelationship among the Conus species we will systematically analyze the venoms for specific ligands.Genetic markers for the cladististic analysis of Conideans will be obtained by PCR amplification of genomicDNA using specific primers.Complete toxin (pre-pro-mature toxin) sequences will be determined by identification of correspondingcDNAs from cDNA libraries constructed from venom-duct mRNA. PCR amplication of cDNA libraries withfamily-specific primers will also be used to determine the repertoire of expressed toxins.Molecular biological methods offer a means of identification of potential ligands (peptides) from very limitedamounts of biological tissue. Conserved primers of different conotoxin superfamilies will be used to identifythe respective toxins from genomic DNA by PCR amplification.The core will continue to provide synthetic peptides and venom samples to the scientific community. Over100 laboratories were supplied during the previous funding period.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
2P01GM048677-16
Application #
7409896
Study Section
Special Emphasis Panel (ZRG1-MDCN-G (40))
Project Start
Project End
Budget Start
2008-07-23
Budget End
2009-01-31
Support Year
16
Fiscal Year
2008
Total Cost
$218,628
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Yan, Yijin; Peng, Can; Arvin, Matthew C et al. (2018) Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission. Cell Rep 23:2236-2244
Hone, Arik J; McIntosh, J Michael (2018) Nicotinic acetylcholine receptors in neuropathic and inflammatory pain. FEBS Lett 592:1045-1062
Hone, Arik J; Talley, Todd T; Bobango, Janet et al. (2018) Molecular determinants of ?-conotoxin potency for inhibition of human and rat ?6?4 nicotinic acetylcholine receptors. J Biol Chem 293:17838-17852
Banala, Sambashiva; Arvin, Matthew C; Bannon, Nicholas M et al. (2018) Photoactivatable drugs for nicotinic optopharmacology. Nat Methods 15:347-350
Hone, Arik J; Servent, Denis; McIntosh, J Michael (2018) ?9-containing nicotinic acetylcholine receptors and the modulation of pain. Br J Pharmacol 175:1915-1927
Espino, Samuel S; Robinson, Samuel D; Safavi-Hemami, Helena et al. (2018) Conopeptides promote itch through human itch receptor hMgprX1. Toxicon 154:28-34
Richter, Katrin; Sagawe, Sabrina; Hecker, Andreas et al. (2018) C-Reactive Protein Stimulates Nicotinic Acetylcholine Receptors to Control ATP-Mediated Monocytic Inflammasome Activation. Front Immunol 9:1604
Hiller, Sebastian Daniel; Heldmann, Sarah; Richter, Katrin et al. (2018) ?-Nicotinamide Adenine Dinucleotide (?-NAD) Inhibits ATP-Dependent IL-1? Release from Human Monocytic Cells. Int J Mol Sci 19:
Peng, Can; Yan, Yijin; Kim, Veronica J et al. (2018) Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission. Eur J Neurosci :
Chen, De-Jie; Gao, Fen-Fei; Ma, Xiao-Kuang et al. (2018) Pharmacological and functional comparisons of ?6/?3?2?3-nAChRs and ?4?2-nAChRs heterologously expressed in the human epithelial SH-EP1 cell line. Acta Pharmacol Sin 39:1571-1581

Showing the most recent 10 out of 277 publications